Literature DB >> 20644008

Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase.

Isabella Baruscotti1, Federica Barchiesi, Edwin K Jackson, Bruno Imthurn, Ruth Stiller, Jai-Hyun Kim, Sara Schaufelberger, Marinella Rosselli, Christopher C W Hughes, Raghvendra K Dubey.   

Abstract

Endothelial progenitor cells (EPCs) repair damaged endothelium and promote capillary formation, processes involving receptor tyrosine kinases (RTKs) and heme oxygenase 1 (HO-1). Because estradiol augments vascular repair, we hypothesize that estradiol increases EPC proliferation and capillary formation via RTK activation and induction of HO-1. Physiological concentrations of estradiol (10 nmol/L) increased EPC-induced capillary sprout and lumen formation in matrigel/fibrin/collagen systems. Propyl-pyrazole-triol (PPT; 100 nmol/L; estrogen receptor [ER]-alpha agonist), but not diarylpropionitrile (ER-beta agonist), mimicked the stimulatory effects of estradiol on capillary formation, and methyl-piperidino-pyrazole (ER-alpha antagonist) abolished the effects of estradiol and PPT. Three different RTK activators (vascular endothelial growth factor, hepatocyte growth factor, and stromal derived growth factor 1) mimicked the capillary-stimulating effects of estradiol and PPT. SU5416 (RTK inhibitor) blocked the stimulatory effects of estradiol and PPT on capillary formation. Estradiol increased HO-1 expression by 2- to 3-fold, an effect blocked by SU5416, and PPT mimicked the effects of estradiol on HO-1. The ability of estradiol to enhance capillary formation, increase expression of HO-1, and augment phosphorylation of extracellular signal-regulated kinase 1/2, Akt, and vascular endothelial growth factor receptor 2 was mimicked by its cell-impermeable analog BSA estradiol. Actinomycin (transcription inhibitor) did not alter the effects of estradiol on RTK activity or vascular endothelial growth factor secretion. We conclude that estradiol via ER-alpha promotes EPC-mediated capillary formation by a mechanism that involves nongenomic activation of RTKs and HO-1 activation. Estradiol in particular and ER-alpha agonists in general may promote healing of injured vascular beds by promoting EPC activity leading to more rapid endothelial recovery and capillary formation after injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20644008      PMCID: PMC2936691          DOI: 10.1161/HYPERTENSIONAHA.110.153262

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  22 in total

Review 1.  Estrogen and angiogenesis: A review.

Authors:  D W Losordo; J M Isner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

Review 2.  Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms.

Authors:  R K Dubey; E K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2001-03

3.  Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Authors:  H N Hodis; W J Mack; R A Lobo; D Shoupe; A Sevanian; P R Mahrer; R H Selzer; C R Liu Cr; C H Liu Ch; S P Azen
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

4.  Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta.

Authors:  Yan Zhu; Zhao Bian; Ping Lu; Richard H Karas; Lin Bao; Daniel Cox; Jeffrey Hodgin; Philip W Shaul; Peter Thoren; Oliver Smithies; Jan-Ake Gustafsson; Michael E Mendelsohn
Journal:  Science       Date:  2002-01-18       Impact factor: 47.728

5.  Lack of hypoxic stimulation of VEGF secretion from neutrophils and platelets.

Authors:  P Koehne; C Willam; E Strauss; R Schindler; K U Eckardt; C Bührer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-08       Impact factor: 4.733

6.  Association of estrogen receptor beta (ESR2) gene polymorphism with blood pressure.

Authors:  S Ogawa; M Emi; M Shiraki; T Hosoi; Y Ouchi; S Inoue
Journal:  J Hum Genet       Date:  2000       Impact factor: 3.172

Review 7.  Effect of heme oxygenase-1 on vascular function and disease.

Authors:  Jozef Dulak; Agnieszka Loboda; Alicja Jozkowicz
Journal:  Curr Opin Lipidol       Date:  2008-10       Impact factor: 4.776

Review 8.  Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis.

Authors:  Jozef Dulak; Jessy Deshane; Alicja Jozkowicz; Anupam Agarwal
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

Review 9.  Non-genomic regulation of vascular cell function and growth by estrogen.

Authors:  Matthias R Meyer; Elvira Haas; Eric R Prossnitz; Matthias Barton
Journal:  Mol Cell Endocrinol       Date:  2009-03-25       Impact factor: 4.102

10.  Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism.

Authors:  Jessy Deshane; Sifeng Chen; Sergio Caballero; Anna Grochot-Przeczek; Halina Was; Sergio Li Calzi; Radoslaw Lach; Thomas D Hock; Bo Chen; Nathalie Hill-Kapturczak; Gene P Siegal; Jozef Dulak; Alicja Jozkowicz; Maria B Grant; Anupam Agarwal
Journal:  J Exp Med       Date:  2007-03-05       Impact factor: 14.307

View more
  14 in total

1.  Age-dependent renal cortical microvascular loss in female mice.

Authors:  Victor H Urbieta-Caceres; Farhan A Syed; Jing Lin; Xiang-Yang Zhu; Kyra L Jordan; Caitlin C Bell; Michael D Bentley; Amir Lerman; Sundeep Khosla; Lilach O Lerman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

2.  Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.

Authors:  Magdalena Kozakowska; Krzysztof Szade; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

Review 3.  Estrogen, hormonal replacement therapy and cardiovascular disease.

Authors:  Xiao-Ping Yang; Jane F Reckelhoff
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-03       Impact factor: 2.894

4.  Adenosine, Via A2B Receptors, Inhibits Human (P-SMC) Progenitor Smooth Muscle Cell Growth.

Authors:  Raghvendra K Dubey; Isabella Baruscotti; Ruth Stiller; Juergen Fingerle; Delbert G Gillespie; Zaichuan Mi; Brigitte Leeners; Bruno Imthurn; Marinella Rosselli; Edwin K Jackson
Journal:  Hypertension       Date:  2019-12-02       Impact factor: 10.190

Review 5.  Role of estrogen in angiogenesis in cardiovascular diseases.

Authors:  Oche Barnabas; Hong Wang; Xiu-Mei Gao
Journal:  J Geriatr Cardiol       Date:  2013-12       Impact factor: 3.327

6.  Chemoattraction of bone marrow-derived stem cells towards human endometrial stromal cells is mediated by estradiol regulated CXCL12 and CXCR4 expression.

Authors:  Xiuli Wang; Ramanaiah Mamillapalli; Levent Mutlu; Hongling Du; Hugh S Taylor
Journal:  Stem Cell Res       Date:  2015-04-24       Impact factor: 2.020

7.  Estrogen-mediated hemangioma-derived stem cells through estrogen receptor-α for infantile hemangioma.

Authors:  Ling Zhang; Hai Wei Wu; Weien Yuan; Jia Wei Zheng
Journal:  Cancer Manag Res       Date:  2017-07-07       Impact factor: 3.989

8.  Red Yeast Rice Protects Circulating Bone Marrow-Derived Proangiogenic Cells against High-Glucose-Induced Senescence and Oxidative Stress: The Role of Heme Oxygenase-1.

Authors:  Jung-Tung Liu; Huey-Yi Chen; Wen-Chi Chen; Kee-Ming Man; Yung-Hsiang Chen
Journal:  Oxid Med Cell Longev       Date:  2017-05-06       Impact factor: 6.543

9.  The aromatase gene (CYP19A1) variants and circulating hepatocyte growth factor in postmenopausal women.

Authors:  Jennifer H Lin; Marc J Gunter; JoAnn E Manson; Kathryn M Rexrode; Nancy R Cook; Peter Kraft; Barbara B Cochrane; Rowan T Chlebowski; Gloria Y F Ho; Shumin M Zhang
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Sex Differences in Circulating Progenitor Cells.

Authors:  Matthew L Topel; Salim S Hayek; Yi-An Ko; Pratik B Sandesara; Ayman Samman Tahhan; Iraj Hesaroieh; Ernestine Mahar; Greg S Martin; Edmund K Waller; Arshed A Quyyumi
Journal:  J Am Heart Assoc       Date:  2017-10-03       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.